Margins Falter despite strong revenue growth: In Q1FY19, total revenues of Alembic Pharma increased by 33% YoY to Rs 8.6 bn (above our estimates Rs 8.0 bn). The Company's operating marginsincreased from 15.7% to 17.5% YoY (our estimates 20%).